Leading the way in improving outcomes for Lung Cancer patients at LHCH with innovative research in areas such as:
- The benefits of screening patients who are at high risk of lung cancer
- Cancer vaccines to stimulate the immune system to be able to recognise cancer cells as abnormal and destroy them.
- The use of Epidermal growth factor receptor inhibitors to stop the cancer cells from dividing and therefore growing.
- The use of erythropoietin to stimulate the body to make more red blood cells as a treatment for anaemia which may occur during chemotherapy treatment.